PregnancyMYMILKNCT01548313
The Role of Human Milk in Development of Breast Fed Child's Intestinal Microbiota
An observational study of Pregnancy and Lactation, run by University of Ljubljana at 1 site in Slovenia.
Trial summary
The ideal food for normal infants is human milk. In addition, breast milk has been shown to be a continuous source of commensal, and⁄or probiotic bacteria to the infant gut where they play a key role in the initiation and development of the gut microbiota. Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- How many people
- 294 participants
- Where
- 1 siteSlovenia
- Study dates
- May 2010to May 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Slovenian, otherwise healthy pregnant women, plan to fully breastfeed their baby for at least 6 weeks, willingness to write a 7-day weighted dietary protocol (7DP) twice: during pregnancy and again at 4 weeks post partum.
Who may be able to join
- healthy pregnant women
- living in Slovenia
- intend to fully breast-feed their babies at least 6 weeks after delivery
- willing to write a 4-day weighted dietary protocol (7DP) twice: during pregnancy and again at 4 weeks post partum
Who cannot join
- autoimmune chronic diseases
- acute and chronic infections
- increased risk for premature delivery
Trial locations and contacts
1 site in 1 country.
Slovenia1 site
University Medical Centre Ljubljana, Division of Paediatrics, Department of Neonatology
Ljubljana, 1000
About this study
The ideal food for normal infants is human milk. In addition, breast milk has been shown to be a continuous source of commensal, and⁄or probiotic bacteria to the infant gut where they play a key role in the initiation and development of the gut microbiota. Intestinal colonization is essential for maturation of the gut-associated lymphoid tissue (GALT) and the homeostasis of the intestinal epithelium. Colonization begins immediately after birth, while later the composition of the gut microbiota is affected by feeding practices. Results of some studies suggest that long-chain polyunsaturated fatty acids (LCPUFAs) promote the adhesion of probiotics to mucosal surfaces and along with probiotic bacteria contribute to the regulation of innate and adaptive immune responses and present a link among mother's diet, and microbes. The main purpose of the proposed research is to establish the link among mothers' nutrition, human milk LCPUFAs composition and microbiota and their potential influence on child's gut microbiota development. Pregnant women from three different regions of Slovenia will be involved into the study. Dietary intakes will be assessed during pregnancy, at the beginning of the 3rd trimester of pregnancy, and during lactation, at 4 weeks post partum, by 7-day weighed dietary protocol (7DP). Human milk (colostrum, and mature human milk) and infant's faeces will be sampled twice: at 2 or 3rd day post partum (meconium) and at 4 weeks post partum for the determination of human milk LCPUFAs composition and the assessment of human milk (colostrum und mature) and faeces microbiota. The fatty acid composition of human milk will be analysed by capillary gas-liquid chromatography (GC). Microbiota of milk and faeces will be studied using conventional microbiological and modern molecular approach such as qualitative and quantitative PCR amplification of informative genomic regions, DGGE/TGGE and/or t-RFLP and sequencing. Regular monthly meetings with the researchers will be organised for discussion and advising. Basic health parameters of infants will be followed. Data will be gathered from maternity department medical charts, from regular paediatric health care visits and from especially designed health care diary each mother will keep until the end of her child's first year.
Read the detailed description
The main goal of the proposed study is to establish the link among mothers' nutrition, human milk LCPUFAs composition and microbiota and their potential influence on child's gut microbiota development. Since the information about the mothers´ diet, about the microbiota and fatty acids composition of human milk, about the faecal microbiota of infants and about the possible mechanisms of eventual transfer of microorganisms from mother to child will be needed to establish these connections. In addition, the influence of vitamine D levels in maternal blood on the bone mineral density in neonates will be determined in the first year of life. The dietary fatty acid composition of plasma lipids in the blood of pregnant women will be assessed.
Mothers and their respective infants will be recruited in the maternity hospitals in three Slovenian regions: Ljubljana, Murska Sobota and Izola. Pregnant women will be invited to participate in the study by informative leaflets during their first visits in the health care centres or gynaecological clinics. All pregnant women who will express interest to participate and fulfilling the participation criteria will be invited to the introductory meeting where they will be informed about the study and will get during 1-hour course, instructions about the writing of 4-day weighed dietary protocol. The meetings will be carried out in the selected regional maternity hospitals. All volunteers willing to participate in the study will get the possibility to get our opinion about their diet during the pregnancy as well as later, during lactation period. The volunteers pregnant women will be also asked to precisely register every probiotic food product or food supplement which they will eat during the last three months of pregnancy and during 4 weeks after delivery.
Informed consent:
The study will be described to pregnant women by principal investigator and/or co-investigators. Following the explanation, the interested pregnant women will be given a written description of the study and the approved informed consent to sign. One copy of the signed document will be provided to the mother and one copy will be retained in the records of the clinical study.
The mothers and respective infants fulfilling the participation criteria for further research will receive written instructions and especially designed health care diary for follow up child's first year health and performance.
The mother will give the second or the third day after the delivery, under the supervision of medical staff, the sample of colostrum. If available, the sample of infant´ meconium will be taken at the same time. Both samples will be subjected to the analyses of microbiota. Samples of mature human milk will be taken under the supervision of medical staff at the first visit of the paediatrician, i.e. 4 weeks after delivery (for determination of fatty acids and microbiota), and again between 12th and 14th week after delivery. Mothers will be asked to bring with also a sample of child's faeces. Cooperation between researchers and respective paediatricians in the health care centres responsible for the infants involved in the study will be also established in order to get insight in the basic data about the development and health of infants.
All infants will be followed up from birth to the age of 12 months according to: a) growth, b) feeding regime, c) development d) bone mineral density and e) health. During their first 12 months of life examinations will take part on six occasions:
- Immediately after birth and during the first three days of life
- At first month (age 28 to 38 days)
- At third month (age 80 to 100 days)
- At sixth month (age 110 to 130 days)
- At ninth month (age 260 to 280 days)
- At twelfth month of age (age 355 to 375 days).
For following growth, development and health standard paediatrics' protocols will be used. Feeding regime will be annotated as:
- exclusively breast feed (BF)
- partially BF (BF + formula)
- only formula. Data will be gathered from maternity department medical charts, from regular paediatric health care visits at the dispensaries and from especially designed health care diary each mother will keep until the end of her child's first year.
The researchers will be responsible for the collecting and keeping records of data about all volunteers involved, of their diaries and of data obtained from paediatricians from health care centres.
Long-chain polyunsaturated fatty acids (LCP), especially docosahexaenoic acid (DHA, C22:6n-3) play an important role for the optimal development and maturation of the nervous system. Adequate supply of LCP, especially of DHA, plays an important role during the period of accelerated growth and differentiation of fetal nervous system during the last trimester of pregnancy and in the first year of life. Recently new Consensus recommendations on dietary fat intake in pregnancy and lactation were issued. We aim to investigate whether dietary intake of Slovenian pregnant and lactating women is in accordance with those new recommendations as well as if their dietary intake is healthy.
Special attention will be given to consumption of LCP and probiotic fermented dairy products. The consumption of probiotic food supplements will be registered as well.
Pregnant women (n=300) from three regions of Slovenia, i.e. Ljubljana with surrounding area (n=100), Izola with surrounding area (n=100) and Murska Sobota with surrounding area (n=100), will be included in the study.
Diet will be examined by the use of 4-day weighed dietary protocol (4DP) which will be done twice:
- during the pregnancy: in the last third of pregnancy (between 27th and 28th week of pregnancy)
- during the breast-feeding: 4 weeks after delivery
Objectives:
- to investigate weather nutrition of pregnant and lactating Slovenian women is in accordance with the Central European dietary guidelines
- to investigate whether nutrition of pregnant and lactating Slovenian is in accordance with the recent consensus recommendations on dietary fat intake during pregnancy and lactation
- to evaluate the frequencies of consumption of probiotic products (data will be important for screening the breast milk for the presence of commercially important probiotics)
During the study mothers will continue with their ordinary diet. For all participating women, a lecture and one-hour course with practical examples and demonstrations by the use of a balance and examples of foods, about how to write a 4-day weighed dietary protocol (4DP) will be organised. After the evaluation of diaries, the mothers will also have a possibility to ask for an expert opinion about their diet during the pregnancy as well as during lactation.
At the University Medical Centre of Ljubljana, Division of Paediatrics, the collected data will be evaluated by the help of computer program Prodi 5.2 Expert plus (Stuttgart, Germany). Energy will be expressed as a daily intake in kcal and MJ. Nutrient intakes will be expressed in (micro) grams/day, while carbohydrate, protein and fat intakes will also be expressed as a percentage of contribution to the daily energy intake. The intake of sea fish and the fatty acids, especially of DHA as well as the intake of probiotic products will be also precisely evaluated.
The nutrition of pregnant and breast-feeding mothers will be compared with the Central European reference intakes, D-A-CH (D-German, A-Austrian; CH-Swiss) Reference Values for Nutrient Intake which are official in Slovenia since 2004. The intake of fats, especially of DHA, will be compared with the recent consensus recommendations on fat intake during pregnancy and lactation. As the D-A-CH Reference Values do not define the maximum amount of daily sodium and sugar intake, we will compare the sodium and sugar intake with the joint WHO/FAO recommendations (population nutrient intake goal for sodium: < 2 g/day and for free sugars: < 10 % of daily energy intake). The proportion of n-3 LCP in plasma lipids of pregnant women will be compared to their diet. The blood obtained from the pregnant women will be analysed for the content of D vitamine and fatty acids composition of plasma lipids. The purpose of these additional test will be
- to establish whether the consumption of marine fish as well as supplements containing fish oil or unicellular organisms with n-3 LCP (EPA and DHA) (capsules, syrups), before and during pregnancy affects the increase of n-3 LCP in plasma lipids, and
- to assess the influence of dietary factors on bone mineral density in women, and the influence of the levels of vitamin D in the blood of mothers to the bone mineral density in neonates.
Among pregnant women included in the study of diet of pregnant and breast-feeding mothers in Slovenia, 40 mothers from each of regions will be randomly selected, after evaluating of inclusion and exclusion criteria, for the investigation of fatty-acid composition and microbial composition of human milk as well as analysis of faecal microbiota of infants.
Objectives:
- the assessment of fatty acids composition of human milk, with emphasis on LCPUFAs
- the investigation of the correlation between dietary DHA intake (4DP) and its content (wt. %) in mature human milk
- the assessment of microbial diversity of human colostrum and milk microbiota, with emphasis on bifidobacteria and lactic acid bacteria - potential probiotics
- the assessment of the prevalence of bacteriocin producing lactic acid bacteria in the natural microbiota of human colostrum and milk
- the assessment of microbial diversity of child's meconium and faeces
- comparison of milk and child's faecal microbiota
Statistic evaluation of final results will be performed by independent statistician from the Institute of Biostatistics and Medical informatics which has been already included in the preparation of the protocols of clinical studies (WP1).
- Keywords
- human milk, nutrition, breastfed child, microbiota, fatty acids, intestinal microbiota, probiotics
- Medical subject headings
- Breast Feeding
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Pregnant women from Ljubljana region | Women at 3rd trimester of pregnancy living in the Ljubljana region. | |
| Pregnant women from Izola region | Women at 3rd trimester of pregnancy living in the Izola region. | |
| Pregnant women from Murska Sobota region | Women at 3rd trimester of pregnancy living in the Murska Sobota region. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Effect of nutrition patterns of pregnant and lactating women on fatty acid composition of milk and plasma lipids, vitemine D in blood, bone density and composition of microbiota of colostrum, milk, meconium and child's faeces
Nutrition patterns of pregnant and lactating women will be assessed by 4-day weighed dietary protocol (27.-28. week of pregnancy and 4 weeks after delivery). Fatty acids composition of milk, will be determined 4 weeks post partum and between 12th and 14th week post partum. Microbial composition of human colostrum, milk, child's meconium and faeces with emphasis on bifidobacteria and lactic acid bacteria will be determined 2nd- 3rd day post partum, at 4 weeks post partum and 12th-14th week post partum). The vitamin D and fatty acids in blood will be determined at 27th-37th week of pregnancy.
Measured: from 27th-28th week of pregnancy to 12th-14th week post partum
Secondary outcomes (1)
Health and development of a child
Growth, type of nutrition, development and health status will be observed. The babies will be examined six times: at birth, at 1st month (between 28th and 38th day), at 3rd month (between 80th and 100th day), at 6th month (between 110th and 130th day), at 9th month (between 260th and 280th day) and at 12th month (between 355th and 375th day).The bone density will be determined at birth and at 1st, 3rd and 12th months.
Measured: The first 12 months post partum
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Mar 2012 (estimated)
- Study startMay 2010
- Primary completionMay 2013
- Study completionMay 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for PregnancyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 294 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Ljubljana
- Sponsor type
- University, hospital or other
- Collaborators
- University Medical Centre Ljubljana
- Responsible party
- Sponsor
- Investigators
- Irena Rogelj, Prof., Principal investigator, University of Ljubljana
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01548313
- Sponsor's protocol ID
- J4 3606 BF-UL My milk
- Acronym
- MYMILK
- Status last verified
- Apr 2019
- First submitted
- 5 Mar 2012
- Last updated
- 1 May 2019
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No: Scientific articles
Publications
Obermajer T, Grabnar I, Benedik E, Tusar T, Robic Pikel T, Fidler Mis N, Bogovic Matijasic B, Rogelj I. Microbes in Infant Gut Development: Placing Abundance Within Environmental, Clinical and Growth Parameters. Sci Rep. 2017 Sep 11;7(1):11230. doi: 10.1038/s41598-017-10244-x.
PubMed 28894126Obermajer T, Lipoglavsek L, Tompa G, Treven P, Lorbeg PM, Matijasic BB, Rogelj I. Correction: Colostrum of Healthy Slovenian Mothers: Microbiota Composition and Bacteriocin Gene Prevalence. PLoS One. 2015 Jun 29;10(6):e0132201. doi: 10.1371/journal.pone.0132201. eCollection 2015. No abstract available.
PubMed 26120836Soltirovska Salamon A, Benedik E, Bratanic B, Velkavrh M, Rogelj I, Fidler Mis N, Bogovic Matijasic B, Paro-Panjan D. Vitamin D Status and Its Determinants in Healthy Slovenian Pregnant Women. Ann Nutr Metab. 2015;67(2):96-103. doi: 10.1159/000439093. Epub 2015 Sep 5.
PubMed 26340437Benedik E, Korousic Seljak B, Hribar M, Rogelj I, Bratanic B, Orel R, Fidler Mis N. Comparison of a Web-Based Dietary Assessment Tool with Software for the Evaluation of Dietary Records. Zdr Varst. 2015 Mar 13;54(2):91-7. doi: 10.1515/sjph-2015-0014. eCollection 2015 Jun.
PubMed 27646914Benedik E, Korousic Seljak B, Simcic M, Rogelj I, Bratanic B, Ding EL, Orel R, Fidler Mis N. Comparison of paper- and web-based dietary records: a pilot study. Ann Nutr Metab. 2014;64(2):156-66. doi: 10.1159/000363336. Epub 2014 Aug 9.
PubMed 25116257Robic T, Benedik E, Fidler Mis N, Bratanic B, Rogelj I, Golja P. Challenges in determining body fat in pregnant women. Ann Nutr Metab. 2013;63(4):341-9. doi: 10.1159/000358339. Epub 2014 Mar 6.
PubMed 24603563Obermajer T, Pogacic T. Commentary: Relationship between Milk Microbiota, Bacterial Load, Macronutrients, and Human Cells during Lactation. Front Microbiol. 2016 Aug 17;7:1281. doi: 10.3389/fmicb.2016.01281. eCollection 2016. No abstract available.
PubMed 27581429
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Role of Human Milk in Development of Breast Fed Child's Intestinal Microbiota
- ClinicalTrials.gov ID
- NCT01548313
- Acronym / sponsor ID
- MYMILK / J4 3606 BF-UL My milk
- Keywords
- human milk, nutrition, breastfed child, microbiota, fatty acids, intestinal microbiota, probiotics
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 294 participants (actual)
- Lead sponsor
- University of LjubljanaUniversity, hospital or other
- Collaborators
- University Medical Centre Ljubljana
- Study start
- May 2010
- Primary completion
- May 2013 (actual)
- Study completion
- May 2015 (actual)
- First posted
- 8 Mar 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The ideal food for normal infants is human milk. In addition, breast milk has been shown to be a continuous source of commensal, and⁄or probiotic bacteria to the infant gut where they play a key role in the initiation and development of the gut microbiota. Intestinal colonization is essential for maturation of the gut-associated lymphoid tissue (GALT) and the homeostasis of the intestinal epithelium. Colonization begins immediately after birth, while later the composition of the gut microbiota is affected by feeding practices. Results of some studies suggest that long-chain polyunsaturated fatty acids (LCPUFAs) promote the adhesion of probiotics to mucosal surfaces and along with probiotic bacteria contribute to the regulation of innate and adaptive immune responses and present a link among mother's diet, and microbes. The main purpose of the proposed research is to establish the link among mothers' nutrition, human milk LCPUFAs composition and microbiota and their potential influence on child's gut microbiota development. Pregnant women from three different regions of Slovenia will be involved into the study. Dietary intakes will be assessed during pregnancy, at the beginning of the 3rd trimester of pregnancy, and during lactation, at 4 weeks post partum, by 7-day weighed dietary protocol (7DP). Human milk (colostrum, and mature human milk) and infant's faeces will be sampled twice: at 2 or 3rd day post partum (meconium) and at 4 weeks post partum for the determination of human milk LCPUFAs composition and the assessment of human milk (colostrum und mature) and faeces microbiota. The fatty acid composition of human milk will be analysed by capillary gas-liquid chromatography (GC). Microbiota of milk and faeces will be studied using conventional microbiological and modern molecular approach such as qualitative and quantitative PCR amplification of informative genomic regions, DGGE/TGGE and/or t-RFLP and sequencing. Regular monthly meetings with the researchers will be organised for discussion and advising. Basic health parameters of infants will be followed. Data will be gathered from maternity department medical charts, from regular paediatric health care visits and from especially designed health care diary each mother will keep until the end of her child's first year.
Detailed description
The main goal of the proposed study is to establish the link among mothers' nutrition, human milk LCPUFAs composition and microbiota and their potential influence on child's gut microbiota development. Since the information about the mothers´ diet, about the microbiota and fatty acids composition of human milk, about the faecal microbiota of infants and about the possible mechanisms of eventual transfer of microorganisms from mother to child will be needed to establish these connections. In addition, the influence of vitamine D levels in maternal blood on the bone mineral density in neonates will be determined in the first year of life. The dietary fatty acid composition of plasma lipids in the blood of pregnant women will be assessed.
Mothers and their respective infants will be recruited in the maternity hospitals in three Slovenian regions: Ljubljana, Murska Sobota and Izola. Pregnant women will be invited to participate in the study by informative leaflets during their first visits in the health care centres or gynaecological clinics. All pregnant women who will express interest to participate and fulfilling the participation criteria will be invited to the introductory meeting where they will be informed about the study and will get during 1-hour course, instructions about the writing of 4-day weighed dietary protocol. The meetings will be carried out in the selected regional maternity hospitals. All volunteers willing to participate in the study will get the possibility to get our opinion about their diet during the pregnancy as well as later, during lactation period. The volunteers pregnant women will be also asked to precisely register every probiotic food product or food supplement which they will eat during the last three months of pregnancy and during 4 weeks after delivery.
Informed consent:
The study will be described to pregnant women by principal investigator and/or co-investigators. Following the explanation, the interested pregnant women will be given a written description of the study and the approved informed consent to sign. One copy of the signed document will be provided to the mother and one copy will be retained in the records of the clinical study.
The mothers and respective infants fulfilling the participation criteria for further research will receive written instructions and especially designed health care diary for follow up child's first year health and performance.
The mother will give the second or the third day after the delivery, under the supervision of medical staff, the sample of colostrum. If available, the sample of infant´ meconium will be taken at the same time. Both samples will be subjected to the analyses of microbiota. Samples of mature human milk will be taken under the supervision of medical staff at the first visit of the paediatrician, i.e. 4 weeks after delivery (for determination of fatty acids and microbiota), and again between 12th and 14th week after delivery. Mothers will be asked to bring with also a sample of child's faeces. Cooperation between researchers and respective paediatricians in the health care centres responsible for the infants involved in the study will be also established in order to get insight in the basic data about the development and health of infants.
All infants will be followed up from birth to the age of 12 months according to: a) growth, b) feeding regime, c) development d) bone mineral density and e) health. During their first 12 months of life examinations will take part on six occasions:
- Immediately after birth and during the first three days of life
- At first month (age 28 to 38 days)
- At third month (age 80 to 100 days)
- At sixth month (age 110 to 130 days)
- At ninth month (age 260 to 280 days)
- At twelfth month of age (age 355 to 375 days).
For following growth, development and health standard paediatrics' protocols will be used. Feeding regime will be annotated as:
- exclusively breast feed (BF)
- partially BF (BF + formula)
- only formula. Data will be gathered from maternity department medical charts, from regular paediatric health care visits at the dispensaries and from especially designed health care diary each mother will keep until the end of her child's first year.
The researchers will be responsible for the collecting and keeping records of data about all volunteers involved, of their diaries and of data obtained from paediatricians from health care centres.
Long-chain polyunsaturated fatty acids (LCP), especially docosahexaenoic acid (DHA, C22:6n-3) play an important role for the optimal development and maturation of the nervous system. Adequate supply of LCP, especially of DHA, plays an important role during the period of accelerated growth and differentiation of fetal nervous system during the last trimester of pregnancy and in the first year of life. Recently new Consensus recommendations on dietary fat intake in pregnancy and lactation were issued. We aim to investigate whether dietary intake of Slovenian pregnant and lactating women is in accordance with those new recommendations as well as if their dietary intake is healthy.
Special attention will be given to consumption of LCP and probiotic fermented dairy products. The consumption of probiotic food supplements will be registered as well.
Pregnant women (n=300) from three regions of Slovenia, i.e. Ljubljana with surrounding area (n=100), Izola with surrounding area (n=100) and Murska Sobota with surrounding area (n=100), will be included in the study.
Diet will be examined by the use of 4-day weighed dietary protocol (4DP) which will be done twice:
- during the pregnancy: in the last third of pregnancy (between 27th and 28th week of pregnancy)
- during the breast-feeding: 4 weeks after delivery
Objectives:
- to investigate weather nutrition of pregnant and lactating Slovenian women is in accordance with the Central European dietary guidelines
- to investigate whether nutrition of pregnant and lactating Slovenian is in accordance with the recent consensus recommendations on dietary fat intake during pregnancy and lactation
- to evaluate the frequencies of consumption of probiotic products (data will be important for screening the breast milk for the presence of commercially important probiotics)
During the study mothers will continue with their ordinary diet. For all participating women, a lecture and one-hour course with practical examples and demonstrations by the use of a balance and examples of foods, about how to write a 4-day weighed dietary protocol (4DP) will be organised. After the evaluation of diaries, the mothers will also have a possibility to ask for an expert opinion about their diet during the pregnancy as well as during lactation.
At the University Medical Centre of Ljubljana, Division of Paediatrics, the collected data will be evaluated by the help of computer program Prodi 5.2 Expert plus (Stuttgart, Germany). Energy will be expressed as a daily intake in kcal and MJ. Nutrient intakes will be expressed in (micro) grams/day, while carbohydrate, protein and fat intakes will also be expressed as a percentage of contribution to the daily energy intake. The intake of sea fish and the fatty acids, especially of DHA as well as the intake of probiotic products will be also precisely evaluated.
The nutrition of pregnant and breast-feeding mothers will be compared with the Central European reference intakes, D-A-CH (D-German, A-Austrian; CH-Swiss) Reference Values for Nutrient Intake which are official in Slovenia since 2004. The intake of fats, especially of DHA, will be compared with the recent consensus recommendations on fat intake during pregnancy and lactation. As the D-A-CH Reference Values do not define the maximum amount of daily sodium and sugar intake, we will compare the sodium and sugar intake with the joint WHO/FAO recommendations (population nutrient intake goal for sodium: < 2 g/day and for free sugars: < 10 % of daily energy intake). The proportion of n-3 LCP in plasma lipids of pregnant women will be compared to their diet. The blood obtained from the pregnant women will be analysed for the content of D vitamine and fatty acids composition of plasma lipids. The purpose of these additional test will be
- to establish whether the consumption of marine fish as well as supplements containing fish oil or unicellular organisms with n-3 LCP (EPA and DHA) (capsules, syrups), before and during pregnancy affects the increase of n-3 LCP in plasma lipids, and
- to assess the influence of dietary factors on bone mineral density in women, and the influence of the levels of vitamin D in the blood of mothers to the bone mineral density in neonates.
Among pregnant women included in the study of diet of pregnant and breast-feeding mothers in Slovenia, 40 mothers from each of regions will be randomly selected, after evaluating of inclusion and exclusion criteria, for the investigation of fatty-acid composition and microbial composition of human milk as well as analysis of faecal microbiota of infants.
Objectives:
- the assessment of fatty acids composition of human milk, with emphasis on LCPUFAs
- the investigation of the correlation between dietary DHA intake (4DP) and its content (wt. %) in mature human milk
- the assessment of microbial diversity of human colostrum and milk microbiota, with emphasis on bifidobacteria and lactic acid bacteria - potential probiotics
- the assessment of the prevalence of bacteriocin producing lactic acid bacteria in the natural microbiota of human colostrum and milk
- the assessment of microbial diversity of child's meconium and faeces
- comparison of milk and child's faecal microbiota
Statistic evaluation of final results will be performed by independent statistician from the Institute of Biostatistics and Medical informatics which has been already included in the preparation of the protocols of clinical studies (WP1).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Pregnant women from Ljubljana region | – | –Women at 3rd trimester of pregnancy living in the Ljubljana region. |
| Pregnant women from Izola region | – | –Women at 3rd trimester of pregnancy living in the Izola region. |
| Pregnant women from Murska Sobota region | – | –Women at 3rd trimester of pregnancy living in the Murska Sobota region. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Slovenian, otherwise healthy pregnant women, plan to fully breastfeed their baby for at least 6 weeks, willingness to write a 7-day weighted dietary protocol (7DP) twice: during pregnancy and again at 4 weeks post partum.
Key inclusion criteria (4 listed)
- healthy pregnant women
- living in Slovenia
- intend to fully breast-feed their babies at least 6 weeks after delivery
- willing to write a 4-day weighted dietary protocol (7DP) twice: during pregnancy and again at 4 weeks post partum
Key exclusion criteria (3 listed)
- autoimmune chronic diseases
- acute and chronic infections
- increased risk for premature delivery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Effect of nutrition patterns of pregnant and lactating women on fatty acid composition of milk and plasma lipids, vitemine D in blood, bone density and composition of microbiota of colostrum, milk, meconium and child's faeces
Time frame: from 27th-28th week of pregnancy to 12th-14th week post partum
Nutrition patterns of pregnant and lactating women will be assessed by 4-day weighed dietary protocol (27.-28. week of pregnancy and 4 weeks after delivery). Fatty acids composition of milk, will be determined 4 weeks post partum and between 12th and 14th week post partum. Microbial composition of human colostrum, milk, child's meconium and faeces with emphasis on bifidobacteria and lactic acid bacteria will be determined 2nd- 3rd day post partum, at 4 weeks post partum and 12th-14th week post partum). The vitamin D and fatty acids in blood will be determined at 27th-37th week of pregnancy.
1 secondary outcome
Health and development of a child
Time frame: The first 12 months post partum
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2019.
- Results publication: PubMed 28894126Obermajer T, Grabnar I, Benedik E, Tusar T, Robic Pikel T, Fidler Mis N, Bogovic Matijasic B, Rogelj I. Microbes in Infant Gut Development: Placing Abundance Within Environmental, Clinical and Growth Parameters. Sci Rep. 2017 Sep 11;7(1):11230. doi: 10.1038/s41598-017-10244-x.
- Results publication: PubMed 26120836Obermajer T, Lipoglavsek L, Tompa G, Treven P, Lorbeg PM, Matijasic BB, Rogelj I. Correction: Colostrum of Healthy Slovenian Mothers: Microbiota Composition and Bacteriocin Gene Prevalence. PLoS One. 2015 Jun 29;10(6):e0132201. doi: 10.1371/journal.pone.0132201. eCollection 2015. No abstract available.
- Results publication: PubMed 26340437Soltirovska Salamon A, Benedik E, Bratanic B, Velkavrh M, Rogelj I, Fidler Mis N, Bogovic Matijasic B, Paro-Panjan D. Vitamin D Status and Its Determinants in Healthy Slovenian Pregnant Women. Ann Nutr Metab. 2015;67(2):96-103. doi: 10.1159/000439093. Epub 2015 Sep 5.
- Results publication: PubMed 27646914Benedik E, Korousic Seljak B, Hribar M, Rogelj I, Bratanic B, Orel R, Fidler Mis N. Comparison of a Web-Based Dietary Assessment Tool with Software for the Evaluation of Dietary Records. Zdr Varst. 2015 Mar 13;54(2):91-7. doi: 10.1515/sjph-2015-0014. eCollection 2015 Jun.
- Results publication: PubMed 25116257Benedik E, Korousic Seljak B, Simcic M, Rogelj I, Bratanic B, Ding EL, Orel R, Fidler Mis N. Comparison of paper- and web-based dietary records: a pilot study. Ann Nutr Metab. 2014;64(2):156-66. doi: 10.1159/000363336. Epub 2014 Aug 9.
- Results publication: PubMed 24603563Robic T, Benedik E, Fidler Mis N, Bratanic B, Rogelj I, Golja P. Challenges in determining body fat in pregnant women. Ann Nutr Metab. 2013;63(4):341-9. doi: 10.1159/000358339. Epub 2014 Mar 6.
- Results publication: PubMed 27581429Obermajer T, Pogacic T. Commentary: Relationship between Milk Microbiota, Bacterial Load, Macronutrients, and Human Cells during Lactation. Front Microbiol. 2016 Aug 17;7:1281. doi: 10.3389/fmicb.2016.01281. eCollection 2016. No abstract available.
- Individual participant dataSharing planned: No. Scientific articles
Related trials for Pregnancy
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Irena Rogelj, Prof. principal investigator
University of Ljubljana
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pregnancy and Lactation, run by University of Ljubljana at 1 site in Slovenia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 May 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Slovenia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Effect of nutrition patterns of pregnant and lactating women on fatty acid composition of milk and plasma lipids, vitemine D in blood, bone density and composition of microbiota of colostrum, milk, meconium and child's faeces (time frame: from 27th-28th week of pregnancy to 12th-14th week post partum). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01548313, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2019.